Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Gliosarcoma 20Glioblastoma 20Central Nervous System Neoplasms 17Sarcoma 14Astrocytoma 6Glioma 5Osteosarcoma 4Liposarcoma 4Hemangiosarcoma 4Hemangiopericytoma, Malignant 4Fibrosarcoma 4Brain Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 3Sarcoma, Synovial 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibrosarcoma 2Malignant mesenchymal tumor 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Pheochromocytoma 1Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1Endometrial Neoplasms 1

Interventions

Doxorubicin 9Imatinib Mesylate 6pazopanib 4Ifosfamide 4Radiotherapy 3Gemcitabine 3Docetaxel 3pembrolizumab 2Radiation 2Neoadjuvant Therapy 2Mohs Surgery 2Biopsy 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2selinexor 1saracatinib 1sapanisertib 1ribociclib 1peposertib 1liposomal doxorubicin 1indolepropanol phosphate 1envafolimab 1cixutumumab 1brigimadlin 1avelumab 1X-Rays 1Watchful Waiting 1TTI-621 1Sunitinib 1Specimen Handling 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dermatofibrosarcoma × Chemotherapy, Adjuvant × Sarcoma × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡